← SynDRA
INT-767
SynDRA canonical compound SYN1463915 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | GPBAR1 | NR1H4 |
|---|
| Mechanism of action | FXR agonist |
|---|
All known targets
Mechanisms of action (all sources)
- NR1H4 AGONIST
- GPBAR1 AGONIST
- FXR agonist
Cross-references
Synonyms
- SCHEMBL21743008
- SY467639
- BRD-K33067152-236-01-1
- CS-5007
- INT-767 sodium
- HY-12434
- sodium (R)-3-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butyl sulfate
- SCHEMBL29376050
- 6-ethyl-24-norcholane-3,7,23-triol-23 sulfate
- F85279
- GLXC-10449
- T11661
- C25H43NaO6S
- orb1709407
- MFCD28386211
- 1000403-03-1 (sodium)
- Sulfuric acid sodium 3alpha,7alpha-dihydroxy-6alpha-ethyl-24-nor-5beta-cholane-23-yl ester salt
- SY416548
- DA-54340
- BDBM50618160
- INT767
- GTPL10198
Look up INT-767 in the interactive SynDRA portal →